• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

产甲胎蛋白胃癌的基因进化

Genetic evolution of alpha fetoprotein producing gastric cancer.

作者信息

Fujii H, Ichikawa K, Takagaki T, Nakanishi Y, Ikegami M, Hirose S, Shimoda T

机构信息

Juntendo University School of Medicine, 2-1-1, Hongo, Bunkyo-ko, Tokyo, 113-8421, Japan.

出版信息

J Clin Pathol. 2003 Dec;56(12):942-9. doi: 10.1136/jcp.56.12.942.

DOI:10.1136/jcp.56.12.942
PMID:14645355
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1770145/
Abstract

BACKGROUND

Alpha fetoprotein (AFP) producing gastric cancer is an unusual form of aggressive adenocarcinoma with a complex histological picture, including enteroblastic and hepatoid differentiation.

AIMS

To investigate the genetic events underlying the phenotypic diversity in AFP producing gastric cancer and the ability of these tumours to produce AFP ectopically.

METHODS

Multiple foci from 19 AFP producing gastric adenocarcinomas were microdissected and loss of heterozygosity (LOH) analysis was performed with a panel of microsatellite markers on nine chromosomal arms.

RESULTS

For informative cases, LOH was most frequently detected on 17p (100%), followed by 13q (88%), 3p (87%), 5q and 9p (80%), 11q (70%), 18q (58%), 16q (53%), and 8p (50%). The average fractional allelic loss was 0.72. LOH was detected either homogeneously throughout the microdissected foci, or only in some parts of the neoplastic foci for each case. Heterogeneous patterns of LOH indicated genetic progression and/or divergence in clonal evolution. Furthermore, in six cases with heterogeneous LOH of 13q, 13q LOH was restricted to immunohistochemically AFP positive neoplastic foci.

CONCLUSION

AFP-GC arises as an aggressive clone with extensive LOH and high fractional allelic loss. The presence of heterogeneous patterns of LOH suggested that the AFP producing carcinoma foci might evolve through genetic progression and/or genetic divergence. Silencing of the crucial gene on 13q may be involved in the acquisition of the AFP producing phenotype.

摘要

背景

产生甲胎蛋白(AFP)的胃癌是侵袭性腺癌的一种特殊形式,具有复杂的组织学表现,包括成肝细胞样和肝样分化。

目的

研究产生AFP的胃癌表型多样性背后的遗传事件,以及这些肿瘤异位产生AFP的能力。

方法

对19例产生AFP的胃腺癌的多个病灶进行显微切割,并用一组微卫星标记对9个染色体臂进行杂合性缺失(LOH)分析。

结果

对于有信息价值的病例,LOH最常出现在17p(100%),其次是13q(88%)、3p(87%)、5q和9p(80%)、11q(70%)、18q(58%)、16q(53%)和8p(50%)。平均等位基因缺失率为0.72。在每个病例中,LOH要么在整个显微切割病灶中均匀检测到,要么仅在肿瘤病灶的某些部分检测到。LOH的异质性模式表明克隆进化中的基因进展和/或分歧。此外,在6例13q存在异质性LOH的病例中,13q LOH仅限于免疫组化AFP阳性的肿瘤病灶。

结论

AFP产生的胃癌(AFP-GC)是作为具有广泛LOH和高等位基因缺失率的侵袭性克隆出现的。LOH的异质性模式表明,产生AFP的癌灶可能通过基因进展和/或基因分歧而演变。13q上关键基因的沉默可能与AFP产生表型的获得有关。

相似文献

1
Genetic evolution of alpha fetoprotein producing gastric cancer.产甲胎蛋白胃癌的基因进化
J Clin Pathol. 2003 Dec;56(12):942-9. doi: 10.1136/jcp.56.12.942.
2
Loss of heterozygosity in clonal evolution with genetic progression and divergence in spindle cell carcinoma of the gallbladder.胆囊梭形细胞癌克隆进化过程中杂合性缺失与基因进展和分化
Hum Pathol. 2004 Apr;35(4):418-23. doi: 10.1016/j.humpath.2003.10.026.
3
Loss of heterozygosity analysis shows monoclonal evolution with frequent genetic progression and divergence in esophageal carcinosarcoma.杂合性缺失分析显示,食管癌肉瘤存在单克隆进化,伴有频繁的基因进展和分化。
Hum Pathol. 2004 Mar;35(3):322-7. doi: 10.1016/j.humpath.2003.02.001.
4
Loss of heterozygosity patterns provide fingerprints for genetic heterogeneity in multistep cancer progression of tobacco smoke-induced non-small cell lung cancer.杂合性缺失模式为烟草烟雾诱导的非小细胞肺癌多步骤癌症进展中的遗传异质性提供了指纹图谱。
Cancer Res. 2005 Mar 1;65(5):1664-9. doi: 10.1158/0008-5472.CAN-04-3297.
5
Fractional allele loss data indicate distinct genetic populations in the development of non-small-cell lung cancer.等位基因缺失分数数据表明非小细胞肺癌发展过程中存在不同的基因群体。
Br J Cancer. 1996 Dec;74(12):1968-74. doi: 10.1038/bjc.1996.661.
6
Genetic classification of combined hepatocellular-cholangiocarcinoma.肝细胞-胆管细胞癌的基因分类
Hum Pathol. 2000 Sep;31(9):1011-7. doi: 10.1053/hupa.2000.9782.
7
Genetic classification of intestinal-type and diffuse-type gastric cancers based on chromosomal loss and microsatellite instability.基于染色体缺失和微卫星不稳定性的肠型和弥漫型胃癌的基因分类
Virchows Arch. 2003 Oct;443(4):491-500. doi: 10.1007/s00428-003-0840-0. Epub 2003 Aug 15.
8
Loss of heterozygosity during the development and progression of differentiated adenocarcinoma of the stomach.胃分化型腺癌发生发展过程中的杂合性缺失
J Pathol. 1998 May;185(1):38-43. doi: 10.1002/(SICI)1096-9896(199805)185:1<38::AID-PATH58>3.0.CO;2-T.
9
Loss of heterozygosity in the clonal evolution of flat colorectal neoplasms.扁平结直肠肿瘤克隆进化中的杂合性缺失
J Pathol. 2002 Jul;197(3):298-306. doi: 10.1002/path.1122.
10
Genetics of synchronous uterine and ovarian endometrioid carcinoma: combined analyses of loss of heterozygosity, PTEN mutation, and microsatellite instability.同步性子宫和卵巢子宫内膜样癌的遗传学:杂合性缺失、PTEN 突变及微卫星不稳定性的联合分析
Hum Pathol. 2002 Apr;33(4):421-8. doi: 10.1053/hupa.2002.124118.

引用本文的文献

1
An Interesting Case of Alpha-Fetoprotein (AFP)-Producing Pancreaticoduodenal Tumor.一例罕见的产生甲胎蛋白(AFP)的胰十二指肠肿瘤病例。
Cureus. 2024 Apr 30;16(4):e59384. doi: 10.7759/cureus.59384. eCollection 2024 Apr.
2
Comprehensive Analysis of Genomic Alterations in Hepatoid Adenocarcinoma of the Stomach and Identification of Clinically Actionable Alterations.胃肝样腺癌基因组改变的综合分析及临床可操作改变的鉴定
Cancers (Basel). 2022 Aug 9;14(16):3849. doi: 10.3390/cancers14163849.
3
The Value of Perioperative Chemotherapy for Patients With Hepatoid Adenocarcinoma of the Stomach Undergoing Radical Gastrectomy.围手术期化疗对接受根治性胃切除术的胃肝样腺癌患者的价值。
Front Oncol. 2022 Jan 10;11:789104. doi: 10.3389/fonc.2021.789104. eCollection 2021.
4
Hepatoid esophagogastric adenocarcinoma and tumoral heterogeneity: a case report.肝样型食管胃腺癌与肿瘤异质性:一例报告
J Gastrointest Oncol. 2021 Dec;12(6):3123-3132. doi: 10.21037/jgo-21-287.
5
Hepatoid Adenocarcinoma of the Stomach: Current Perspectives and New Developments.胃肝样腺癌:当前观点与新进展
Front Oncol. 2021 Apr 12;11:633916. doi: 10.3389/fonc.2021.633916. eCollection 2021.
6
Effect of Immune Checkpoint Inhibitors Plus Chemotherapy on Advanced Gastric Cancer Patients with Elevated Serum AFP or Hepatoid Adenocarcinoma.免疫检查点抑制剂联合化疗对血清甲胎蛋白升高的晚期胃癌患者或肝样腺癌患者的疗效
Cancer Manag Res. 2020 Nov 2;12:11113-11119. doi: 10.2147/CMAR.S276969. eCollection 2020.
7
The prognosis of hepatoid adenocarcinoma of the stomach: a propensity score-based analysis.胃肝样腺癌的预后:基于倾向评分的分析。
BMC Cancer. 2020 Jul 17;20(1):671. doi: 10.1186/s12885-020-07031-9.
8
Clinicopathological features and prognosis of AFP-producing colorectal cancer: a single-center analysis of 20 cases.产甲胎蛋白的结直肠癌的临床病理特征及预后:20例单中心分析
Cancer Manag Res. 2019 May 16;11:4557-4567. doi: 10.2147/CMAR.S196919. eCollection 2019.
9
Hepatoid adenocarcinoma of the stomach: a unique subgroup with distinct clinicopathological and molecular features.胃肝样腺癌:具有独特临床病理和分子特征的独特亚群。
Gastric Cancer. 2019 Nov;22(6):1183-1192. doi: 10.1007/s10120-019-00965-5. Epub 2019 Apr 15.
10
Early Gastric Cancer with Purely Enteroblastic Differentiation and No Conventional Adenocarcinoma Component.具有纯肠母细胞分化且无传统腺癌成分的早期胃癌。
Case Rep Pathol. 2018 Aug 28;2018:3620293. doi: 10.1155/2018/3620293. eCollection 2018.

本文引用的文献

1
Genetic classification of combined hepatocellular-cholangiocarcinoma.肝细胞-胆管细胞癌的基因分类
Hum Pathol. 2000 Sep;31(9):1011-7. doi: 10.1053/hupa.2000.9782.
2
Comprehensive allelotype study of hepatocellular carcinoma: potential differences in pathways to hepatocellular carcinoma between hepatitis B virus-positive and -negative tumors.肝细胞癌的全面等位基因分型研究:乙肝病毒阳性和阴性肿瘤在肝细胞癌发生途径上的潜在差异。
Hepatology. 2000 May;31(5):1073-9. doi: 10.1053/he.2000.6409.
3
Hepatoid carcinoma of the stomach: is it still an unusual anatomo-clinical entity? Six cases-report.胃肝样腺癌:它仍然是一种罕见的解剖学 - 临床实体吗?六例报告。
J Exp Clin Cancer Res. 1999 Dec;18(4):571-3.
4
Loss of heterozygosity at chromosome 13q in hepatocellular carcinoma: identification of three independent regions.
Eur J Cancer. 1999 Nov;35(12):1730-4. doi: 10.1016/s0959-8049(99)00205-1.
5
Frequent genetic heterogeneity in the clonal evolution of gynecological carcinosarcoma and its influence on phenotypic diversity.妇科癌肉瘤克隆进化中的频繁基因异质性及其对表型多样性的影响。
Cancer Res. 2000 Jan 1;60(1):114-20.
6
Hepatoid adenocarcinoma of the pancreas.胰腺肝样腺癌
Histopathology. 1999 Jul;35(1):90-2. doi: 10.1046/j.1365-2559.1999.0728f.x.
7
Allelotype of gastric adenocarcinoma.胃腺癌的等位基因型
Cancer Res. 1999 Apr 1;59(7):1437-41.
8
Fractional allelic loss in gastric carcinoma correlates with growth patterns.胃癌中的等位基因分数缺失与生长模式相关。
Oncogene. 1998 Nov 19;17(20):2655-9. doi: 10.1038/sj.onc.1202188.
9
Loss of heterozygosity during the development and progression of differentiated adenocarcinoma of the stomach.胃分化型腺癌发生发展过程中的杂合性缺失
J Pathol. 1998 May;185(1):38-43. doi: 10.1002/(SICI)1096-9896(199805)185:1<38::AID-PATH58>3.0.CO;2-T.
10
Alpha-fetoprotein-producing gastric carcinoma presenting focal hepatoid differentiation in metastatic lymph nodes.转移性淋巴结中出现局灶性肝样分化的产甲胎蛋白胃癌。
Virchows Arch. 1998 Jan;432(1):85-7. doi: 10.1007/s004280050138.